Sofinnova Partners

Company

Investment-firm

Last deal

Amount

Private Equity

Stage

16.05.2022

Date

1

all rounds

Financing round

General

About Company
Sofinnova Partners is a venture capital firm that invests in life sciences.

Industry

Sector :

Subsector :

founded date

01.01.1972

founders

Number of employees

Last funding type

Private Equity

IPO status

Private

Description

The firm invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations in the life sciences sector, with a focus on biopharmaceuticals, biotech, medical devices, and industrial biotechnology. Sofinnova Partners proactively sources deals, takes a lead role, is often the first institutional investor in Round A financings, and sits on the boards of its portfolio companies. Its team of professionals with strong scientific, medical, and business expertise actively partners with entrepreneurs as a lead or cornerstone investor to develop transformative innovations that positively impact the future. Founded in 1972, the firm has over €2 billion of assets under management and is headquartered in Paris, with offices in London and Milan.
Contacts

Contact Email

Phone number

Social url

Similar Companies
999
Decheng Capital

Decheng Capital

Decheng Capital is a venture capital firm that invests in early and growth stage life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Menlo Park, CA, USA

count Of Investments

75

count Of Exists

6
Mosaix Ventures

Mosaix Ventures

Mosaix Ventures is a private equity partnership that supports innovative healthcare and life sciences companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Chicago, IL, USA

count Of Investments

11

count Of Exists

8
Epidarex Capital

Epidarex Capital

Epidarex Capital is a venture capital firm that invests in early-stage life science and health technology companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Bethesda, MD, USA

count Of Investments

39

count Of Exists

2
Spruce Capital Partners

Spruce Capital Partners

Spruce Capital Partners is a venture capital firm that focuses on investing in biogreentech companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Funding Platform

Location

San Francisco, CA, USA

count Of Investments

14

Financials

Funding Rounds
1
1

Number of Funding Rounds

Their latest funding was raised on 16.05.2022. Their latest investor Apollo. Their latest round Private Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
16.05.2022
1
Apollo

Apollo

Apollo Global Management is a high-growth, global alternative asset manager.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

total rounds

8

total raised

$5.1B

count Of Investments

88

count Of Exists

15
Investments
283
Date 
name 
Lead 
type 
Raised 
13.05.2024
No
$25M
20.03.2024
Yes
$16.3M
Local Amount - EUR 15M
14.03.2024
Yes
$32.22M
Local Amount - GBP 25.2M
AblaCare

AblaCare

AblaCare provides a minimally invasive treatment to restore ovulation in women with PCOS-related infertility.

Sector

Health Care Providers

Subsector

Health Care Facilities

Location

Paris, France

total rounds

3

total raised

$36.2M
Cure51

Cure51

Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features.

total rounds

1

total raised

$16.3M
MISSION Therapeutics

MISSION Therapeutics

Mission Therapeutics is a drug discovery company targeting deubiquitylating enzymes.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Cambridge, UK

total rounds

9

total raised

$180.5M
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Private Equity
Apollo

Apollo

Apollo Global Management is a high-growth, global alternative asset manager.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

total rounds

8

total raised

$5.1B

count Of Investments

88

count Of Exists

15

Neil Mehta

current job

Apollo
Apollo
Exits
40
Chroma Medicine

Chroma Medicine

Chroma Medicine revolutionizes treatment of genetic diseases with single-dose epigenetic medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Genetics, Health Care

Location

Cambridge, MA, USA

total rounds

3

total raised

$260M
Revolt Technology

Revolt Technology

ReVolt Technology is a technology company developing rechargeable zinc-air batteries.

Sector

Software and Computer Services

Subsector

Software

Keywords

Electronics, Manufacturing

Location

Portland, OR, USA

total rounds

6

total raised

$42.8M
GlycoVaxyn

GlycoVaxyn

GlycoVaxyn AG develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

8952 Schlieren, Switzerland

total rounds

4

total raised

$34.3M

People

Founders
1
Jean Deleage
Jean Deleage

Jean Deleage

Jean began his venture capital career in 1971 in Paris, France with Sofinnova and started its very successful American subsidiary, Sofinnova, Inc. in 1976 in San Francisco. In 1979, he formed Burr, Egan, Deleage & Co., with Craig Burr and William Egan. During the 1980s and 1990s, BEDCO was a prominent, diversified venture firm. He co-founded Alta in 1996. Jean is an industry leader in biotechnology; he had the vision to start the Alta BioPharma family of funds, one of the very first venture capital initiatives to fund later stage life sciences companies. He was an early investor in many of the leading companies in the field today, including Cephalon, Chiron and Genentech. Jean holds a Masters Degree in Electrical Engineering from the École Supérieure d’Electricité and a Ph.D. in Economics from the Sorbonne. In 1993, Jean was awarded the Legion of Honor by the French government in recognition of his career accomplishments.

current job

Alta Partners
Alta Partners

Jean Deleage

Employee Profiles
58
Edward Kliphuis

Edward Kliphuis

Partner

Tiziana Rossetti

Tiziana Rossetti

Senior Associate

Armance Bordes

Armance Bordes

General Counsel

Maina Bhaman

Maina Bhaman

Partner

Paola Pozzi

Paola Pozzi

Partner, Sofinnova Telethon Fund

Henrijette Richter

Henrijette Richter

Managing Partner

Guillaume Baxter

Guillaume Baxter

Senior Associate

ZhiZhong Yao

ZhiZhong Yao

Principal - biotech/biopharma

Activity

Recent News
36
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week